AI assistant
Sending…
Alligator Bioscience — Major Shareholding Notification 2022
Oct 6, 2022
3138_iss_2022-10-06_42e5136a-0276-4ca7-8bb7-66400bc7555a.pdf
Major Shareholding Notification
Open in viewerOpens in your device viewer

Issuer Alligator Bioscience AB
Holder
Alestra Limited
Instrument
| Instrument | Ordinary Shares | ||
|---|---|---|---|
| Before the transaction | |||
| Shares | 0 | ||
| Voting rights | 0 | ||
| Transaction | |||
| Date | 30/09/2022 | ||
| Limit for number of shares 25 % | |||
| Limit for number of votes | 25 % | ||
| After the transaction | |||
Quantity
| Shares | 55,643,092 |
|---|---|
| Directly held voting rights 55,643,092 | |
| Indirectly held voting rights 0 |
Percentage
| Directly held shares | 25.1171 % |
|---|---|
| Directly held voting rights 25.21439 % | |
| Indirectly held voting rights 0 % |
Resulting distribution of total
| holdings | ||
|---|---|---|
| Percentage of voting rights: |
Number of underlying shares: |
|
| Shares | 25.21439 % | 55,643,092 |
| Instruments - FITA Ch. 4, section 2, first paragraph, line 2 Instruments - FITA Ch. 4, section 2, first paragraph, line 3 |
||
| - Physically settled - Cash settled |
||
| Total | 25.21439 % | 55,643,092 |
| Group total holdings Voting rights 55,643,092 |
||
| Percentage of voting rights 25.21439 | ||
| Published 06/10/2022 10:36 |
||
CLOSE PRINT
[email protected] Tfn 08-408 980 37 Fax 08-24 39 25
More from Alligator Bioscience
AGM Information
2026
May 6
AGM Information
2026
May 6
Interim / Quarterly Report
2026
May 5
Interim / Quarterly Report
2026
May 5
Share Issue/Capital Change
2026
Mar 31
Share Issue/Capital Change
2026
Mar 31
Proxy Solicitation & Information Statement
2026
Mar 30
Proxy Solicitation & Information Statement
2026
Mar 30
Board/Management Information
2026
Mar 27
Board/Management Information
2026
Mar 27